📰 Michael Platten News
Page 2 - Michael Platten News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Michael Platten. Real-time updates on events, politics, business and more.
October 27, 2022
People are buying hot items like the new Top Gun Maverick costume, the new Michael Meyers mask, and of course classics like Scream, Sonic and Scooby-Doo.
August 12, 2022
Clear August skies meant the glowing Moon was captured in all its glory, making for some spectacular shots.
June 12, 2022
Our reviewer Mark Heath and his wife Liz spent the night at the recently re-opened and refurbished Worlington Hall in Suffolk. Here's what they made of it...
June 12, 2022
Our reviewer Mark Heath and his wife Liz spent the night at the recently re-opened and refurbished Worlington Hall in Suffolk. Here's what they made of it...
June 12, 2022
Our reviewer Mark Heath and his wife Liz spent the night at the recently re-opened and refurbished Worlington Hall in Suffolk. Here's what they made of it...
June 10, 2022
All patients in a rectal cancer drug trial were in remission after six months. Experts say it's 'revolutionary' but bigger, more diverse studies are needed.
May 13, 2022
Escape the hustle and bustle of the coast, and retreat inland this summer to one of these luxurious hotels, glamping sites or camping pitches
May 13, 2022
Escape the hustle and bustle of the coast, and retreat inland this summer to one of these luxurious hotels, glamping sites or camping pitches
May 24, 2021
Brain tumor cells with a certain common mutation reprogram invading immune cells. This leads to the paralysis of the bodys immune defense against the tumor in the brain. Researchers from Heidelberg, Mannheim, and Freiburg discovered this mechanism and at the same time identified a way of reactivating the paralyzed immune system to fight the tumor. These results confirm that therapeutic vaccines or immunotherapies are more effective against brain tumors if active substances are simultaneously use...
April 12, 2021
Researchers from Heidelberg have carried out a clinical trial to test a mutation-specific vaccine against malignant brain tumors.